Ars Pharmaceuticals Inc (SPRY)

Income Before Tax

-$62.34M

Quarterly · Period ending: · USD

SPRY logo

SPRY Income Before Tax

Latest reported-$62.34M
SPRY Quarterly Pre-Tax Income (-$6.97M → -$62.34M)
High-resolution chart · PNG

SPRY income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ars Pharmaceuticals Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-62,339,000
-60,618,000
-41,404,000
-51,151,000
-44,883,000
-33,940,000
50,222,000
-19,128,000
-12,516,000
-10,292,000
-7,168,000
-14,866,000
-17,370,000
-14,961,000
-14,429,000
-6,583,000
-6,420,000
-7,250,000
-5,140,000
-5,810,000
-4,646,500
-4,646,500
-13,085,000
-6,467,000
-5,279,000
-6,970,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.